Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational studyDamiano Baroncini, G. Coniglio, Massimo Filippi et al.|Neurological Sciences|2022Cited by 32
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy studySebastiano Bucello, Luca Prosperini, Pietro Annovazzi et al.|Journal of Neurology|2021Cited by 22